Faculty Opinions recommendation of Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
By P. O’Farrell. 2001
1,008 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/7a06410b9371e5652f62f0e718fdaa040b629a2b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- G. Semenza
- C. V. Dang
- Navdeep S. Chandel
- Ralph J. Deberardinis
- P. Schumacker
- Ping Gao
- M. C. Simon
- Jung-whan Kim
In Molecular Biology
- G. Semenza
- C. V. Dang
- Navdeep S. Chandel
- Ralph J. Deberardinis
- P. Schumacker
- Ping Gao
- Jung-whan Kim
- M. C. Simon
In Surgery
- Ralph J. Deberardinis
- K. Guan
- Peng Huang
- C. V. Dang
- Quynh-Thu Le
- M. C. Simon
- Max Costa
- J. F. Stevens
Citations in the corpus
- Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. (2006, background): “Recently, it has been discovered that the prolyl hydroxylase activity responsible for basal degradation of HIF-1 requires iron for activity (275, 276).”
- Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 (2007, background): “Oxygen regulation of HIF-1 levels depends on the HIF-1 oxygen-dependent domain, which contains two prolyl residues (402 and 564), which are hydroxylated by prolyl hydroxylase in the presence of oxygen (4, 33, 34, 52, 70, 73).”
- RING domain E3 ubiquitin ligases. (2009, background): “Indeed, the vast majority of CRL substrates are targeted to their respective ligase by a covalent modification, including glycosylation (117) and proline hydroxylation (118, 119).”
- The role of hypoxia-inducible factors in tumorigenesis (2008, background): “Hydroxylation of conserved proline residues within the HIF-a ODD by prolyl-4hydroxylase domain (PHD)-containing proteins mediates pVHL binding and degradation.(20,21) Under hypoxia, HIF-a subunits are stabilized and translocate to the nucleus, where they heterodimerize with ARNT and bind to HREs loc”
- Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin (2002, background): “The first pathway is triggered by hypoxia or CoCl2 and involves the inhibition of a family of PHDs that modify Pro-564 and Pro-402 of HIF-1 (5, 21, 22, 27, 41).”
- Hypoxia-Inducible Factor-1 (HIF-1) (2006, positive): “2-OG analogs can increase the half-life of HIF-1 (Jaakkola et al., 2001; Ivan et al., 2002).”
- The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche (2010, background): “Hif-1a undergoes hydroxylation, followed by ubiquitination and degradation during normoxia in most cells (Ivan et al., 2001; Jaakkola et al., 2001; Kamura et al., 2000; Maxwell et al., 1999; Salceda and Caro, 1997).”
- Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. (2005, positive): “HIF-α is degraded under normoxia following proline hydroxylation by prolyl hydroxylases (PHDs; Jaakkola et al., 2001; Ivan et al., 2001).”
- Redox Regulation of Cell Survival (2008, positive): “The hydroxylated HIF is then recognized by the von Hippel–Lindau (VHL) ubiquitin E3 ligase complex, which promotes the degradation of HIF-1 by the 26S proteosome (134).”
- Vitamins C and E: Beneficial effects from a mechanistic perspective (2011, background): “Under normoxic conditions, the HIF-1α subunit is targeted for degradation by HIFspecific prolyl hydroxylases that hydroxylate HIF-1α at proline residues 402 and564 [22].”
- Hypoxia inducible mir-210 regulates normoxic gene expression involved in tumor initiation (2009, positive): “Under normoxic conditions, the a subunit of HIF1 is hydroxylated at prolines 402 and 564 by prolyl-4-hydroxylases (PHDs), targeting HIF1a for proteasome destruction mediated by the von Hippel-Lindau (VHL) protein, an E3 ubiquitin ligase (Chan et al., 2005; Ivan et al., 2001; Jaakkola et al., 2001).”
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. (2016, background): “In the presence of oxygen, conserved proline residues on the α-subunit are hydroxylated, promoting its degradation (Ivan et al., 2001; Jaakkola et al., 2001).”